Form D · Biotechnology

Vivex Biomedical, Inc.

Atlanta, GA · CIK 0001581881

Offering snapshot reported May 11, 2017 · SEC filing

Reported sold
$6.28M
Offering amount: $7M
Investors reported
38
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 24, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported investors0 → 38

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 11, 2017Amendment$6,280,065No comparison38SEC filing
Jan 26, 2017InitialYet to sellNo comparison0SEC filing
Jan 5, 2016Initial$6,609,235No comparison42SEC filing
Sep 16, 2013Amendment$7,241,400$5,061,400vs Jul 18, 201351SEC filing
Jul 18, 2013Initial$2,180,000No comparison20SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-279318

Source: Form D, filed May 11, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tracy S. Anderson Director, Executive
Leo Cook Executive
Saadiq El Amin, Iii Director
U. Bertram Ellis, Jr. Director
J. Miguel Fernandez De Castro Director
Timothy Ganey, Ph.D. Executive
Thomas J. Gibson Executive
David Greenberg Director
Thomas Greene Director
Stuart J Komenski Executive
Timothy Lusby Director
John Marsh Executive
Holly Mason Executive
John A. Mc Callum Director
Ricardo J. Nunez Executive
Richard E. Perlman Director
James K. Price Director
Jouko R. Rissanen Director
Michael Rozmajzl Executive
Barry Salzman Director
Jeffrey A. Smith Director
Timothy Taylor Director
H. Thomas Temple Director
Dr. H. Thomas Temple Executive
Dr. H Thomas Temple Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3200 Windy Hill Road Suite 1650 W
Atlanta, GA, 30339